FAST (Focused Abbreviated Screening Technique)-MRI Study

Part of paid clinical trials in Los Angeles, California.

Sponsor
Icahn School of Medicine at Mount Sinai
Study ID
NCT04539717
Status
Enrolling By Invitation

Conditions

  • Hepatocellular Carcinoma (HCC)
  • Liver Cirrhosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to compare the diagnostic value of a reconstructed abbreviated Magnetic Resonance Imaging (MRI) from a full clinical exam, compared to ultrasound (US) for screening of liver cancer. Blood markers will be evaluated to determine their correlation to imaging. This study will help to determine whether abbreviated MRI is superior to ultrasound for diagnosis of liver cancer.

Key Dates

Start date
Aug 17, 2020
Status verified
Oct 2025
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
820 participants (estimated)

Primary Outcome Measure

Presence of HCC [ Time Frame: Within 6 months after initial index imaging (MRI & US) ]

Locations (2)

FacilityCityStateZIPSite coordinators
Cedars-Sinai Medical CenterLos AngelesCalifornia90048-
Icahn School of Medicine at Mount SinaiNew YorkNew York10029-

Find similar trials in Los Angeles, CA

By research site
Cedars-Sinai Medical Center· Los Angeles, CAIcahn School of Medicine at Mount Sinai· New York, NY

Related Studies